Selected article for: "antiviral agent and broad spectrum antiviral agent"

Author: Tsang, Kenneth W.
Title: Severe Acute Respiratory Syndrome (SARS)
  • Cord-id: kzirtmbw
  • Document date: 2016_10_24
  • ID: kzirtmbw
    Snippet: Severe acute respiratory syndrome (SARS) is caused by a novel coronavirus (SARS-CoV), spread largely via droplets. Patients present with rapidly progressive pneumonia and respiratory failure. Diagnosis requires the demonstration of epidemiological linkage, clinical profiles, and virological evidence of SARS-CoV infection. Treatment of SARS is largely anecdotal. High-dose corticosteroid therapy might be useful for critically ill patients, but previous use of ribavirin (a broad-spectrum antiviral
    Document: Severe acute respiratory syndrome (SARS) is caused by a novel coronavirus (SARS-CoV), spread largely via droplets. Patients present with rapidly progressive pneumonia and respiratory failure. Diagnosis requires the demonstration of epidemiological linkage, clinical profiles, and virological evidence of SARS-CoV infection. Treatment of SARS is largely anecdotal. High-dose corticosteroid therapy might be useful for critically ill patients, but previous use of ribavirin (a broad-spectrum antiviral agent) was probably not efficacious. Some survivors of SARS suffer from avascular necrosis of hip and knee joints. Poor prognostic factors include advanced age, comorbidities, and high serum lactate dehydrogenase and neutrophil levels.

    Search related documents:
    Co phrase search for related documents
    • abdominal pain and liver transaminase: 1, 2
    • abdominal pain and low molecular weight: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • abdominal pain and low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • abdominal pain and low mortality: 1, 2
    • abdominal pain and lung consolidation: 1, 2, 3, 4
    • acute respiratory syndrome and adenovirus vector vaccine: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute respiratory syndrome and liver transaminase: 1, 2, 3, 4, 5, 6, 7
    • acute respiratory syndrome and low molecular weight: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and low mortality: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and lung consolidation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and lung interstitium: 1, 2, 3, 4
    • adenovirus vector vaccine and low molecular weight: 1
    • adenovirus vector vaccine and low molecular weight heparin: 1
    • liver transaminase and lung consolidation: 1
    • low mortality and lung consolidation: 1